Ninlaro
Brand Name: Ninlaro
Generic Name: Ixazomib (as citrate)
Active
Registration Number
DR-XY46358
Dosage Form
Capsule
Issuance Date
April 14, 2023
Expiry Date
April 14, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2.3 mg
PackagingPVC-Aluminium/Aluminium blister strip containing three
capsules, sealed inside a wallet pack. One wallet pack is packaged in one carton (Box of 3's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Protease Inhibitor)
A
Application
Monitored Release (Variation)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Ixazomib (as citrate)Active
Monograph: Ixazomib